Why is this ASX 200 healthcare share jumping 7% today?

This healthcare share is getting a lot of love from investors today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Ltd (ASX: RHC) share price is having a strong session on Wednesday.

In morning trade, the ASX 200 healthcare share is up 7% to $58.68.

Young doctor raising arms in air with hands in fists celebrating a new development

Image source: Getty Images

Why is this ASX 200 healthcare share racing higher?

Investors have been bidding Ramsay Health Care shares higher today after the private hospital operator released a couple of announcements.

The first announcement reveals that the company is looking to offload its 50% owned Ramsay Sime Darby Health Care (RSD) joint venture in Asia.

The release notes that the decision was made following the receipt of significant inbound interest in RSD at values that it feels are in shareholders' interests to explore. Though, it warns that there is no certainty that a sale process will result in a completed transaction.

Ramsay also revealed that the business continues to perform strongly, with its equity accounted contribution for the 9 months to 31 March 2023 up 31.7% to $16.2 million.

What else?

A second announcement reveals that the ASX 200 healthcare share has refinanced its bank loan facilities.

According to the release, the company has secured $1.5 billion in new committed revolving bank loan facilities with two of its key relationship banks.

The facilities, which will mature in FY 2026, are part of Ramsay Health Care's ongoing bank loan refinancing activities. They will be used to repay facilities maturing in FY 2025.

Management also advised that it will continue to seek to diversify the source and tenor of its borrowings over time.

While today's gain is of course good news for shareholders, it does not change much for them on a 12-month basis. Since this time last year, the ASX 200 healthcare share has lost almost 21% of its value.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

Up 2,000% in a year, why this ASX healthcare stock is in focus today

4DMedical shares rise as multiple updates land across key markets.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Orthocell caps 26% surge this week with first US Military Surgery

The company's commercial rollout is off to a good start.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

This ASX health tech stock just hit a new record high. Could it go even higher?

Morgans believes there's still upside to be had.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Down almost 20% this year, how high could Mesoblast shares go?

The forward pipeline is looking promising.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares?

These three stocks might be too cheap to ignore.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Healthcare Shares

How much would $10,000 become if CSL shares returned to their record high?

After a sharp decline, CSL is in a new phase. The question is what happens next.

Read more »

A man clenches his fists with glee having seen the share price go up on the computer screen in front of him.
Healthcare Shares

Why this ASX biotech stock just rocketed 89% today

Immutep shares rocket after a fresh FDA win

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Orthocell shares soar 22% on landmark US breakthrough

The company has been given approval to sell Remplir in more than 220 hospitals in the US.

Read more »